Candesartan cilexetil impurity E is a chemical compound identified as a process-related impurity of the active pharmaceutical ingredient candesartan cilexetil. It is a structurally related benzimidazole derivative carrying ester and ether functionalities, used as a reference standard in pharmaceutical quality control.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 914613-35-7
Trityl candesartan cilexetil
pharmaceutical intermediate
Candesartan cilexetil
pharmaceutical raw material
Dactolisib
pharmaceutical raw material
Flurbiprofen axetil
pharmaceutical raw material
(R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
pharmaceutical raw material
Enzalutamide
pharmaceutical raw material
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(1-ethyltetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
HKUZPIFWPFYKBZ-UHFFFAOYSA-N
CCN1C(=NN=N1)C2=CC=CC=C2C3=CC=C(C=C3)CN4C5=C(C=CC=C5N=C4OCC)C(=O)OC(C)OC(=O)OC6CCCCC6